New methods of integrating aptamers with various types of nanomaterials are summarized, highlighting promising classes of aptamer-conjugated nanoparticles for efficient cancer cell recognition and the targeted delivery of drugs. In addition, emerging technologies for cancer treatment using nanomaterials as therapeutic drugs are discussed. These aptamer-conjugated nanomaterials will benefit cancer treatment through increased specificity and efficacy as well as reduced toxicity.
- Qiaoling Liu
- Chen Jin
- Weihong Tan